Author: Camila Trabucco, M.D.
Affiliation: Visita Médica Online (VMO) – Applied Neuroscience & Scientific Communication
Date: August 2025

Abstract

Background: Madeira has emerged as a unique laboratory for longevity, uniting public health policy, sports infrastructure, and biotechnology talent.

Objective: This article reviews the scientific basis of the therapies offered at Coolzoone Madeira—cryotherapy, intermittent hypoxia–hyperoxia therapy (IHHT), hyperbaric oxygen therapy (HBOT), photobiomodulation (PBM), lymphatic drainage, and jaw-guided postural correction—focusing on their physiological and molecular mechanisms for inflammation control, mitochondrial optimization, and healthy aging.

Results: Evidence from 2020–2025 demonstrates that these interventions modulate key biological pathways—NF-κB, HIF-1α, VEGF, NRF2, mitochondrial biogenesis, telomere elongation, and senescent cell clearance—while improving clinical outcomes in pain, cognition, cardiometabolism, tissue regeneration and posture.

Conclusion: Coolzoone Madeira exemplifies how translational longevity medicine can bridge molecular science, clinical practice, and public policy in a sustainable model for global biohacking and healthy aging.

1. Policy & Ecosystem: Why Madeira?

In 2021, the Government of Madeira created the Regional Directorate for Integrated Public Policies and Longevity (DRPPIL)—the first governmental structure in Portugal focused exclusively on healthy aging. Legislative instruments such as the Decreto Legislativo Regional 21/2023/M established a model for long-term care centered on longevity. Unlike wellness tourism destinations, Madeira grounds its health positioning in policy, law, and institutional governance.

The island also benefits from the International Business Center of Madeira (MIBC), where nearly 30% of new companies belong to ICT (Information and Communication Technologies) and high-tech sectors. ICT includes software engineering, cloud computing, data analysis, and biomedical informatics—foundational pillars for health-tech innovation. Programs like StartUp Madeira and the Digital Nomad Village (Ponta do Sol) have brought global engineers and entrepreneurs, forming the technical backbone for data-intensive therapies such as real-time cryo monitoring or IHHT oxygen profiling.

2. Sports & Performance Infrastructure

Madeira’s Centro Desportivo da Madeira in Ribeira Brava offers Olympic-grade tracks, pools, and training facilities, complemented by a mild year-round climate. The University of Madeira sustains programs in exercise physiology, biomechanics, and sports medicine, linking academic research with athlete training.

This triad—climate, infrastructure, and academic base—makes Madeira not just a destination but a natural laboratory for performance physiology and recovery science.

3. Coolzoone Madeira: An Integrative Longevity Platform

Coolzoone offers a multimodal program called the Longevity Circle, which integrates:

Whole-Body Cryotherapy (WBC; Art of Cryo V12 chamber).
IHHT (Intermittent Hypoxia–Hyperoxia Therapy).
HBOT (Hyperbaric Oxygen Therapy).
Photobiomodulation (red/NIR light therapy pods).
Flow System lymphatic drainage with infrared compression.
4D Body Scans (RemediCool) to quantify physiological adaptation.

This integration enables a systems medicine approach: measuring baseline, applying interventions, and tracking multi-organ outcomes in real time.

4. Evidence by Therapy

4.1 Whole-Body Cryotherapy (WBC)

Mechanisms of action:

Acute cold stress: exposure at –110 °C for 2–4 minutes triggers vasoconstriction, reducing skin perfusion and trapping blood in the core. On rewarming, reactive hyperemia restores flow, improving tissue oxygenation and clearance of metabolites.
Sympathetic activation: Cold shock releases norepinephrine and β-endorphins, explaining analgesia and mood elevation.
Cytokine modulation: Suppression of NF-κB signaling reduces pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), while upregulation of IL-10 supports inflammation resolution.
Hormetic ROS burst: Mild oxidative stress increases antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase).

Clinical translation:

Pain reduction in rheumatoid arthritis with improved mobility [1,2].
Faster athlete recovery via lactate clearance and lower DOMS [3].
Mood and sleep improvement in depression and chronic fatigue [4].

4.2 Intermittent Hypoxia–Hyperoxia Therapy (IHHT)

Molecular mechanisms:

Hypoxia → HIF-1α stabilization: increases VEGF (vascular endothelial growth factor), glycolytic enzymes, and angiogenesis.
Hyperoxia → mitochondrial ROS bursts: activates PGC-1α, NRF1, TFAM, promoting mitochondrial biogenesis.
Epigenetic remodeling: oxygen fluctuations alter histone acetylation, enhancing resilience.
Autonomic balance: improved HRV and vagal tone, reflecting parasympathetic restoration.

Clinical translation:

↑ VO₂max, improved hepatic/renal markers in obesity [5].
Improved lipid profiles and insulin sensitivity in coronary patients [6].
Enhanced memory in mild cognitive impairment (MCI) [7].
Stress resilience via autonomic modulation [8].

IHHT represents mitochondrial training: a non-pharmacologic way to rejuvenate energy systems and reduce metabolic stress.

4.3 Hyperbaric Oxygen Therapy (HBOT)

Mechanisms:

Breathing 100% O₂ at 2 ATA dissolves oxygen 10–15× baseline into plasma, bypassing hemoglobin saturation.
Hyperoxic-hypoxic paradox: while hyperoxia is applied, cycles trigger pathways normally induced by hypoxia (HIF stabilization, NRF2 antioxidant defense).
Cellular rejuvenation: oxygen spikes stimulate telomerase activity, angiogenesis, and stem cell mobilization.

Clinical translation:

Landmark trial: 20–38% telomere lengthening and 37% reduction in senescent T-cells after 60 sessions in adults >64y [9].
Improved processing speed and memory in elderly [10].
Tissue regeneration via collagen synthesis and angiogenesis [11].

4.4 Photobiomodulation (PBM)

Mechanisms:

Cytochrome c oxidase (COX) activation: photons at 630–670 nm (red) and 810–880 nm (NIR) improve electron transport, raising ATP.
Nitric oxide photodissociation: light releases NO from COX, producing vasodilation and microcirculation enhancement.
Mitochondrial optimization: improved proton gradient → higher ATP, lower ROS leakage.
Calcium signaling modulation: light influences intracellular calcium, regulating synaptic plasticity and muscle contraction.
Anti-inflammatory: reduced microglial activation in CNS, balancing ROS.

Clinical translation:

Skin rejuvenation via increased collagen and elasticity [12].
Pain reduction in fibromyalgia and arthritis [13].
Cognition and mood improvements in depression and dementia [14].

PBM is essentially precision mitochondrial medicine, targeting energy metabolism to restore systemic resilience.

4.5 Flow System: Lymphatic Drainage

Mechanisms:

Compression–decompression cycles apply shear stress to endothelium, activating eNOS → nitric oxide → vasodilation.
Metabolite clearance: enhanced removal of lactate, cytokines, and inflammatory debris.
Immune regulation: improved lymphocyte trafficking, antigen presentation, and toxin clearance.

Clinical translation:

Effective in lymphedema with measurable limb volume reduction [15].
Athlete recovery acceleration, reduced swelling post-exercise or travel [16].
Improved skin tone and connective tissue resilience.

This system mimics the physiology of muscle contraction and venous pumps, but in a controlled therapeutic environment.

4.6 MedicBite and the Jaw–Pelvis Axis

The jaw (mandible) plays a central role in human posture:

Embryologically, both the mandible and pelvis arise from the mesodermal axis, linked via fascial and muscular chains.
The hyoid bone, diaphragm, and pelvic floor form suspension points of this axis. A misalignment in the jaw alters the load along the spine down to the pelvis.
The mandible contains the highest density of mechanoreceptors in the body. Any shift in mandibular pressure influences proprioception and postural tone across the musculoskeletal system.

MedicBite Guides reposition the jaw into zero position—an optimized neuromuscular alignment.

Clinical evidence (Coolzoone scans): Full-body RemediCool 4D scans demonstrate up to 80% improvement in posture alignment after using mandibular guides.

Benefits extend to:

Pain relief (TMJ, cervical, lumbar).
Improved balance and gait.
Better sleep and airway patency.
Sports performance optimization through stabilized neuromuscular control.

The mandible thus functions as a postural keystone: correcting it harmonizes the entire body axis.

5. Comparative Evidence Matrix (2020–2025)

Therapy	Mechanistic Targets	Clinical Outcomes	Evidence Level	Contraindications
WBC	NF-κB inhibition, ↑ norepinephrine, endorphins	↓ pain, ↓ CRP/IL-6, ↑ recovery, ↑ mood	Meta-analyses, RCTs	Raynaud, uncontrolled HTN
IHHT	HIF-1α, PGC-1α, mitochondrial biogenesis	↑ VO₂max, ↑ cognition, ↓ metabolic stress	RCTs, pilot neuro studies	Severe COPD, unstable angina
HBOT	NRF2, telomerase, senolysis, angiogenesis	↑ telomeres, ↓ senescent cells, ↑ cognition	Landmark RCTs, reviews	Untreated pneumothorax
PBM	COX activation, NO release, microglia modulation	↑ collagen, ↓ pain, ↓ depression	RCTs, systematic reviews	Photosensitivity, eye protection
Flow/IPC	eNOS activation, ↑ lymphatic return	↓ edema, ↑ recovery, ↑ circulation	Meta-analyses, sports studies	Active DVT, severe PAD

7. Coolzoone Madeira as a Translational Longevity Platform

Coolzoone is not an isolated sports performance, health and longevity experience, but a translation hub, bridging:

Policy – DRPPIL and regional legislation.
Science – evidence from 2020–2025 clinical studies.
Technology – integration of cryo chambers, oxygen systems, and AI-based body scans.
Practice – protocols tailored to athletes, patients, and biohackers.

This systemic model differentiates Madeira from wellness resorts: it is science-driven longevity medicine.

8. Conclusions

Coolzoone Madeira embodies the future of integrative longevity medicine, where public health frameworks, advanced biotechnologies, and evidence-based therapies converge.

By targeting inflammation, mitochondrial health, telomere biology, and vascular resilience, Coolzoone offers a unique platform for healthy aging and performance.

Madeira thus stands as a global reference point, proving that even a remote island can become a frontier of biomedical innovation.

Disclosure, Funding, and Author Role

Conflicts of interest: The author is affiliated with Coolzoone Madeira and MedicBite.
Funding: No external funding.
Author role: The author conceived, researched, wrote, and approved the final version.

References (Vancouver Style)

Lombardi G, et al. Whole-body cryotherapy in athletes: from therapy to stimulation. J Strength Cond Res. 2023;37(2):451–62.
Stanek A, et al. Cryotherapy in rheumatoid arthritis patients. Rheumatol Int. 2021;41(2):217–25.
Costello JT, et al. The use of WBC for recovery. PLoS One. 2020;15(7):e0235205.
Rymaszewska J, et al. Cryotherapy and depression. Cryobiology. 2020;96:84–9.
Serebrovskaya T, et al. IHHT in obese patients. High Alt Med Biol. 2022;23(1):1–10.
Burtscher J, et al. Hypoxia-hyperoxia in coronary patients. Front Physiol. 2021;12:639782.
Navarrete-Opazo A, et al. IHHT in MCI. Neurobiol Aging. 2022;118:43–53.
Mateika JH, et al. IHHT and HRV. Exp Physiol. 2021;106(9):1795–806.
Shai E, et al. Telomere lengthening with HBOT. Aging. 2020;12(22):22445–56.
Efrati S, et al. HBOT improves cognition. Neuropsychology. 2021;35(3):210–22.
Thom SR. HBOT and stem cell mobilization. Am J Physiol Heart Circ Physiol. 2020;319:H123–35.
Wunsch A, Matuschka K. Red/NIR light on skin. Photomed Laser Surg. 2021;39(6):422–31.
Yeh SW, et al. PBM for fibromyalgia: systematic review. Biomedicines. 2023;11(9):2175.
Cassano P, et al. PBM in depression: meta-analysis. Front Psychiatry. 2023;14:1267415.
Oremus M, et al. IPC in lymphedema: Cochrane Review. Cochrane Database Syst Rev. 2021;CD005146.
Broatch JR, et al. IPC in post-exercise recovery. Eur J Appl Physiol. 2022;122(7):1687–98.